Biofil Chem & Pharma Stock Price Analysis and Quick Research Report. Is Biofil Chem & Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Biofil Chem & Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Biofil Chem & Pharma has a PE ratio of 106.414584740041 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Biofil Chem & Pharma has ROA of 5.9398% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Biofil Chem & Pharma has a Current ratio of 1.7334.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Biofil Chem & Pharma has a ROE of 16.9767%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Biofil Chem & Pharma has a Debt to Equity ratio of 0.1696 which means that the company has low proportion of debt in its capital.

• Sales growth: Biofil Chem & Pharma has reported revenue growth of -14.99% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Biofil Chem & Pharma for the current financial year is 2.28700625457824%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Biofil Chem & Pharma is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Biofil Chem & Pharma is Rs 0.2962. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Biofil Chem & Pharma in Ticker for free. Also, one can get the intrinsic value of Biofil Chem & Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Biofil Chem & Pharma FAQs

Q1. What is Biofil Chem & Pharma share price today?
Ans: The current share price of Biofil Chem & Pharma is Rs 31.52.

Q2. What is the market capitalisation of Biofil Chem & Pharma?
Ans: Biofil Chem & Pharma has a market capitalisation of Rs 51.2950176 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Biofil Chem & Pharma?
Ans: The PE ratio of Biofil Chem & Pharma is 106.414584740041 and the P/B ratio of Biofil Chem & Pharma is 2.86384038087623, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Biofil Chem & Pharma share?
Ans: The 52-week high share price of Biofil Chem & Pharma is Rs 46.34, and the 52-week low share price of Biofil Chem & Pharma is Rs 25.6.

Q5. Does Biofil Chem & Pharma pay dividends?
Ans: Currently, Biofil Chem & Pharma does not pay dividends. Dividend yield of Biofil Chem & Pharma is around 0%.

Q6. What are the face value and book value of Biofil Chem & Pharma shares?
Ans: The face value of Biofil Chem & Pharma shares is Rs 10, while the book value per share of Biofil Chem & Pharma is around Rs 11.0062. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Biofil Chem & Pharma?
Ans: Biofil Chem & Pharma has a total debt of Rs 3.02 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Biofil Chem & Pharma?
Ans: The ROE of Biofil Chem & Pharma is 16.9767% and ROCE of Biofil Chem & Pharma is 19.055%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Biofil Chem & Pharma a good buy for the long term?
Ans: The Biofil Chem & Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Biofil Chem & Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Biofil Chem & Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Biofil Chem & Pharma’s financials?
Ans: You can review Biofil Chem & Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.